Mahkam Zanganeh
Chief Executive Officer presso SUMMIT THERAPEUTICS INC.
Patrimonio netto: 153 M $ in data 31/03/2024
Posizioni attive di Mahkam Zanganeh
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| PULSE BIOSCIENCES, INC. | Director/Board Member | 10/02/2017 | - |
| Independent Dir/Board Member | 10/02/2017 | - | |
| SUMMIT THERAPEUTICS INC. | Director/Board Member | 11/11/2020 | - |
| Chief Executive Officer | 25/07/2022 | - | |
| President | 25/07/2022 | - | |
| Chief Operating Officer | 22/11/2020 | 25/07/2022 | |
| Image-Guided Hybrid Surgery Institute | Director/Board Member | - | - |
| Maky Zanganeh & Associates, Inc. | Chief Executive Officer | 01/01/2016 | - |
| Founder | 01/01/2016 | - | |
Summit Therapeutics Ltd.
 Summit Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Summit Therapeutics Ltd. operates as a holding company, which engages in the discovery, development, and commercialization of antibiotic medicines. The company seeks to expand its product candidate portfolio through the development of new mechanism and precision antibiotics. Summit Therapeutics was founded by Stephen Graham Davies and Kay Dame Davies in January 2003 and is headquartered in Abingdon, the United Kingdom. | Director/Board Member | 01/11/2020 | - |
| Chief Executive Officer | - | - | |
| President | - | - | |
| Chief Operating Officer | 01/11/2020 | - |
Storia della carriera di Mahkam Zanganeh
Precedenti posizioni note di Mahkam Zanganeh
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| RENOVORX, INC. | Director/Board Member | 01/01/2018 | 01/08/2021 |
| Independent Dir/Board Member | 01/01/2018 | 01/08/2021 | |
| PHARMACYCLICS, INC. | Chief Operating Officer | 08/08/2012 | 01/09/2015 |
| Human Resources Officer | 01/12/2011 | 08/08/2012 | |
| Corporate Officer/Principal | 01/08/2008 | 30/11/2011 | |
Pharmacyclics, Inc.
 Pharmacyclics, Inc. Pharmaceuticals: MajorHealth Technology Pharmacyclics, Inc. develops drugs to treat cancer. The private company is based in Sunnyvale, CA. Robert William Duggan has been the CEO of the company since 2015. | Chief Operating Officer | 01/08/2012 | 01/09/2015 |
Robert W. Duggan & Associates
 Robert W. Duggan & Associates Investment ManagersFinance Robert W. Duggan & Associates provides investment advisory services. The firm also offers portfolio management, financial planning, and consulting services. The company was founded by Robert W. Duggan and is headquartered in Santa Barbara, CA. | Corporate Officer/Principal | 01/08/2008 | 01/08/2008 |
| ░░░░░░░░ ░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
| ░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
Formazione di Mahkam Zanganeh
| Schiller International University (France) | Masters Business Admin |
| Louis Pasteur University | Doctorate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 8 |
| Francia | 4 |
| Regno Unito | 3 |
Posizioni
| Director/Board Member | 7 |
| Chief Operating Officer | 4 |
| Corporate Officer/Principal | 3 |
Settori
| Health Technology | 8 |
| Consumer Services | 3 |
| Finance | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| RENOVORX, INC. | Health Technology |
| Aziende private | 11 |
|---|---|
Pharmacyclics LLC
 Pharmacyclics LLC Pharmaceuticals: MajorHealth Technology Pharmacyclics LLC engages in developing and commercializing innovative small-molecule drugs for the treatment of cancer and immune mediated diseases. It has product candidates in clinical development and several preclinical molecules in optimization. The company was founded by Jonathan Sessler and Richard Miller in 1991 and is headquartered in Sunnyvale, CA. | Health Technology |
Computer Motion, Inc.
 Computer Motion, Inc. Medical SpecialtiesHealth Technology Computer Motion, Inc. developed and manufactured computer-enhanced robotic surgical systems. The company was headquartered in Goleta, CA. | Health Technology |
Summit Therapeutics Ltd.
Summit Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Summit Therapeutics Ltd. operates as a holding company, which engages in the discovery, development, and commercialization of antibiotic medicines. The company seeks to expand its product candidate portfolio through the development of new mechanism and precision antibiotics. Summit Therapeutics was founded by Stephen Graham Davies and Kay Dame Davies in January 2003 and is headquartered in Abingdon, the United Kingdom. | Health Technology |
| Pulse Biosciences, Inc. | |
Robert W. Duggan & Associates
Robert W. Duggan & Associates Investment ManagersFinance Robert W. Duggan & Associates provides investment advisory services. The firm also offers portfolio management, financial planning, and consulting services. The company was founded by Robert W. Duggan and is headquartered in Santa Barbara, CA. | Finance |
Oxstem Ltd.
 Oxstem Ltd. BiotechnologyHealth Technology Oxstem Ltd. develops cell programming therapies. The company is headquartered in Oxford, the United Kingdom. | Health Technology |
Human Longevity, Inc.
 Human Longevity, Inc. BiotechnologyHealth Technology Human Longevity, Inc. provides precision health analytics to individuals through the Health Nucleus. The Health Nucleus is an assessment of current and future risk for cardiac, oncologic, metabolic and cognitive diseases and conditions. The firm offers database of sequenced genomes and phenotypic data. The company was founded by J. Craig Venter, Robert Joseph Hariri Gordon, and Peter H. Diamandis in 2013 and is headquartered in San Diego, CA. | Health Technology |
| Summit Therapeutics, Inc. | |
| Maky Zanganeh & Associates, Inc. | |
Pharmacyclics, Inc.
Pharmacyclics, Inc. Pharmaceuticals: MajorHealth Technology Pharmacyclics, Inc. develops drugs to treat cancer. The private company is based in Sunnyvale, CA. Robert William Duggan has been the CEO of the company since 2015. | Health Technology |
| Image-Guided Hybrid Surgery Institute |
- Borsa valori
- Insiders
- Mahkam Zanganeh
- Esperienza
